Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 4
1990 3
1991 3
1992 3
1993 4
1994 3
1995 4
1996 6
1997 9
1998 9
1999 3
2000 5
2001 7
2002 5
2003 6
2004 6
2005 4
2006 6
2007 8
2008 11
2009 17
2010 17
2011 16
2012 25
2013 23
2014 31
2015 36
2016 25
2017 25
2018 27
2019 32
2020 23
2021 26
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

399 results
Results by year
Filters applied: . Clear all
Page 1
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study.
Hosomi Y, Morita S, Sugawara S, Kato T, Fukuhara T, Gemma A, Takahashi K, Fujita Y, Harada T, Minato K, Takamura K, Hagiwara K, Kobayashi K, Nukiwa T, Inoue A; North-East Japan Study Group. Hosomi Y, et al. Among authors: gemma a. J Clin Oncol. 2020 Jan 10;38(2):115-123. doi: 10.1200/JCO.19.01488. Epub 2019 Nov 4. J Clin Oncol. 2020. PMID: 31682542 Clinical Trial.
Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.
Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I, Fujita Y, Okinaga S, Hirano H, Yoshimori K, Harada T, Ogura T, Ando M, Miyazawa H, Tanaka T, Saijo Y, Hagiwara K, Morita S, Nukiwa T; North-East Japan Study Group. Maemondo M, et al. Among authors: gemma a. N Engl J Med. 2010 Jun 24;362(25):2380-8. doi: 10.1056/NEJMoa0909530. N Engl J Med. 2010. PMID: 20573926 Free article. Clinical Trial.
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.
Saito H, Fukuhara T, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Gemma A, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M. Saito H, et al. Among authors: gemma a. Lancet Oncol. 2019 May;20(5):625-635. doi: 10.1016/S1470-2045(19)30035-X. Epub 2019 Apr 8. Lancet Oncol. 2019. PMID: 30975627 Clinical Trial.
Exosome-Derived microRNA-22 Ameliorates Pulmonary Fibrosis by Regulating Fibroblast-to-Myofibroblast Differentiation in Vitro and in Vivo.
Kuse N, Kamio K, Azuma A, Matsuda K, Inomata M, Usuki J, Morinaga A, Tanaka T, Kashiwada T, Atsumi K, Hayashi H, Saito Y, Seike M, Gemma A. Kuse N, et al. Among authors: gemma a. J Nippon Med Sch. 2020 Jul 13;87(3):118-128. doi: 10.1272/jnms.JNMS.2020_87-302. Epub 2019 Nov 28. J Nippon Med Sch. 2020. PMID: 31776321 Free article.
Real-World Evaluation of Factors for Interstitial Lung Disease Incidence and Radiologic Characteristics in Patients With EGFR T790M-positive NSCLC Treated With Osimertinib in Japan.
Gemma A, Kusumoto M, Sakai F, Endo M, Kato T, Saito Y, Baba T, Sata M, Yamaguchi O, Yabuki Y, Nogi Y, Jinushi M, Sakamoto K, Sugeno M, Tamura R, Tokimoto T, Ohe Y. Gemma A, et al. J Thorac Oncol. 2020 Dec;15(12):1893-1906. doi: 10.1016/j.jtho.2020.08.025. Epub 2020 Sep 11. J Thorac Oncol. 2020. PMID: 32927121 Free article.
A roadmap for molecular thermoelectricity.
Gemma A, Gotsmann B. Gemma A, et al. Nat Nanotechnol. 2021 Dec;16(12):1299-1301. doi: 10.1038/s41565-021-01012-0. Nat Nanotechnol. 2021. PMID: 34887535 No abstract available.
[Pemetrexed].
Sudoh J, Gemma A. Sudoh J, et al. Among authors: gemma a. Gan To Kagaku Ryoho. 2008 Jun;35(6):1033-8. Gan To Kagaku Ryoho. 2008. PMID: 18633241 Japanese.
[Iressa (gefitinib)].
Kudoh S, Yoshimura A, Gemma A. Kudoh S, et al. Among authors: gemma a. Gan To Kagaku Ryoho. 2003 Aug;30(8):1079-84. Gan To Kagaku Ryoho. 2003. PMID: 12938261 Review. Japanese.
399 results